회사의 펀더멘털은 비교적 아주 건전한한 편입니다. 회사의 밸류에이션은 적정하게 평가된으로 간주됩니다. 기관의 인지도는 매우 높은입니다. 지난 30일 동안 여러 애널리스트들이 이 회사를 보유로 평가했습니다. 주식시장에서 부진한 성과에도 불구하고, 회사는 강한 펀더멘털을 보이고 있습니다. 주가는 지지선과 저항선 사이에서 횡보하고 있으며, 범위 매매 기반의 스윙 트레이딩에 적합한 상황입니다.
Quanterix Corp 점수
관련 정보
산업 순위
95 / 210
전체 순위
226 / 4615
산업
의료 장비 및 공급품
저항선 & 지지선
데이터 없음
레이더 차트
현재 가격
과거
분석가 목표가
4
명의 분석가를 기준으로
유지
현재 등급
6.250
목표 가격
+20.89%
상승 여력
면책 조항: 애널리스트 평가 및 목표 주가는 정보 제공을 위한 목적으로 LSEG에서 제공되며, 투자 조언으로 간주되지 않습니다.
Quanterix Corp 주요 내용
강점위험 요소
Quanterix Corporation is a life sciences company. The Company is engaged in developing ultra-sensitive digital immunoassay platforms that advance precision health for life sciences research and diagnostics. Its platforms are based on its digital Simoa detection technology. Its Simoa bead-based and planar array platforms enable customers to detect protein biomarkers in low concentrations in blood, serum, and other fluids. The Company's Simoa technology is based on traditional enzyme-linked immunosorbent assay (ELISA) technology. Its products include HD-X, SR-X, SP-X, Simoa assays and consumables, and NfL antibodies and NfL ELISA kits. It also offers contract research services for customers through its Accelerator Laboratory, which provides customers with access to Simoa technology and supports multiple projects and services, including sample testing, homebrew assay development and custom assay development. It has completed over 2,200 projects for 480 customers using its Simoa platforms.
높은 성장
회사의 매출은 지난 3년간 꾸준히 성장해왔으며, 연평균 30.23%의 증가율을 기록했습니다.
Quanterix Corporation is a life sciences company. The Company is engaged in developing ultra-sensitive digital immunoassay platforms that advance precision health for life sciences research and diagnostics. Its platforms are based on its digital Simoa detection technology. Its Simoa bead-based and planar array platforms enable customers to detect protein biomarkers in low concentrations in blood, serum, and other fluids. The Company's Simoa technology is based on traditional enzyme-linked immunosorbent assay (ELISA) technology. Its products include HD-X, SR-X, SP-X, Simoa assays and consumables, and NfL antibodies and NfL ELISA kits. It also offers contract research services for customers through its Accelerator Laboratory, which provides customers with access to Simoa technology and supports multiple projects and services, including sample testing, homebrew assay development and custom assay development. It has completed over 2,200 projects for 480 customers using its Simoa platforms.